ASPERGILLUS GALACTOMANNAN Ag VIRCLIA®
Invasive Aspergillosis: The Urgency of Rapid and Accurate Diagnosis to Save Lives
Invasive Aspergillosis is a severe infection caused by the Aspergillus fungus, which primarily affects individuals with weakened immune systems, such as those undergoing chemotherapy, organ transplants, or suffering from advanced HIV/AIDS. Unlike mild forms of aspergillosis, the invasive type can spread quickly from the lungs to other parts of the body, including the brain, kidneys, and heart, making it life-threatening.
The importance of rapid and accurate diagnosis cannot be overstated, as delays in identifying and treating invasive aspergillosis can result in high mortality rates. Early detection allows for timely antifungal treatment, improving outcomes and significantly reducing the risk of complications. Given its rapid progression, accurate diagnostic tools are crucial for effectively managing the infection in vulnerable patients.
Save time, save lives
> No sample accumulation
> The true monotest
1 sample= 1 reportable result. No waste of reagents
Individual quality control per monotest
> Fully automated protocol with VirClia® Lotus
Combine with more than 90 parameters for infectious diseases.
Join the Revolution in Infectious Serology
> Excellence performance against the gold standard in the market
VirClia® has been evaluated vs a commercial ELISA
A recent publication versus a commercial ELISA as a reference, providing high sensitivity and specificity. VIRCLIA® showed excellent results when analyzing clinical samples compatible with invasive aspergillosis according EORTC/MSGERC criteria.
Publications and Media
Vircell in Fungal Congresses
Advances Against Aspergillosis and Mucormycosis
Vircell is proud to have participated for several years in the Advances Against Aspergillosis & Mucormycosis Conference. This prestigious event brings together leading fungal experts from around the globe.
Trends in Medical Mycology | 19-22 September 2025
The 12th Trends in Medical Mycology (TIMM-12) will be held in Bilbao, Spain. It will gather over 1,000 experts to discuss fungal biology, diagnostics, and antifungal resistance. TIMM offers networking and insights into both research and clinical application.
Balkan Fungus 2024 | 10-12 October
This year Dr. Snezana Jovanovic from Clinical Center of Serbia will talk about her Routine with Aspergillus and CAGTA on VirClia Monotest in her speech.
Other Events
Check our upcoming events
Technical Specifications
Sandwich Chemiluminescent Immunoassay (CLIA) for the detection of Aspergillus galactomannan antigen in serum, plasma and human bronchoalveolar lavage (BAL) samples.
- Same day results, no batching, no sample cumulation.
- On-demand testing: One monotest = one reportable result. Nothing else is required.
- Simple and fully automated protocol with results in about 1h 15minutes, sample pretreatment needed.
- Objective method with reported results in index values.
- Compatible test with the broadest panel of infectious diseases in CLIA monotest format (>90 parametres).
Ordering information
